Insights and guidance on life sciences accounting issues0257
Accounting in life sciences is ever-evolving, with new challenges surfacing as new business priorities take hold. No matter where a company finds itself today, Deloitte’s 2022 Life Sciences Industry Accounting Guide can help its accounting team address the unique set of issues it faces.
Life sciences accounting: Answers to today’s pressing questions
Finance and accounting professionals in the life sciences industry face a range of complex issues specific to their organization’s needs and priorities. For each one, accounting teams must exercise significant judgment in applying existing rules. It can seem daunting.
Deloitte’s 2022 Life Sciences Industry Accounting Guide is here to help bring clarity. An accounting manual for pharmaceutical and biotech companies and others in the life sciences industry, professionals can use the guide throughout the year to address established accounting or reporting issues like revenue recognition, research and development, acquisitions and divestitures, contingencies, and income taxes. They can also learn how to handle new trends in the industry like the reporting consequences of environmental, social, and governance (ESG) strategies and initial public offerings (IPOs).
